# US 2024/0181008 A1 · Methods for promoting wound healing and hair growth

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0181008 A1
- Document ID: US20240181008A1
- Status: Published application
- Kind: A1
- Application number: 18/529,590
- Filed: 2023-12-05
- Published: 2024-06-06
- Earliest claimed: 2013-03-15
- Assignees: The Jackson Laborartory
- Applicants: The Jackson Laborartory
- Inventors: Robert E. Braun; Manju Sharma
- Web page: https://patentgrep.com/patent/US20240181008A1

## CPC

- A61K 38/185: {Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3}
- A61G 7/00: Beds specially adapted for nursing; Devices for lifting patients or disabled persons (stretchers with facilities for picking up patients or disabled persons A61G1/003)
- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 17/14: for baldness or alopecia
- A61Q 7/00: Preparations for affecting hair growth
- C07K 14/4756: {Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61G: TRANSPORT, PERSONAL CONVEYANCES OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS (appliances for aiding patients or disabled persons to walk A61H3/00); OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES (embalming corpses A01N1/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention generally relates to uses of glial cell line-derived growth factor (GDNF) in cutaneous wound healing and hair growth. Methods of effecting hair growth and/or wound healing which feature administration of GDNF, or a biologically active fragment thereof, to subjects, e.g., human subject, are disclosed herein. The invention relates also to formulations and kits for achieving the indicated pharmaceutical advantages.

## Claims

### Claim at position 1

-23. (canceled)

### Claim 24

A method for promoting hair growth comprising:
administering to skin comprising hair follicles of a subject in need thereof a therapeutically effective amount of a topical formulation comprising recombinant human glial cell-derived neurotrophic factor (GDNF), wherein the therapeutically effective amount increases the number of hair follicles in the skin of the subject.

### Claim 25 (depends on 24)

The method of claim 24, wherein the subject has androgenetic alopecia.

### Claim 26 (depends on 24)

The method of claim 24, wherein the subject has acute or chronic telogen effluvium.

### Claim 27 (depends on 24)

The method of claim 24, wherein the topical formulation is administered to the scalp of the subject.

### Claim 28 (depends on 24)

The method of claim 24, wherein the topical formulation is an emulsion.

### Claim 29 (depends on 28)

The method of claim 28, wherein the emulsion is a continuous phase emulsion.

### Claim 30 (depends on 28)

The method of claim 28, wherein the emulsion is a disperse phase emulsion.

### Claim 31 (depends on 28)

The method of claim 28, wherein the emulsion is a cream, lotion, ointment, or gel.

### Claim 32 (depends on 28)

The method of claim 28, wherein the emulsion is an oil-in-water emulsion or a water-in-oil emulsion.

### Claim 33 (depends on 28)

The method of claim 28, wherein the emulsion is a microemulsion.

### Claim 34 (depends on 24)

The method of claim 24, wherein the therapeutically effective amount is administered daily for at least 3-5 days.

### Claim 35 (depends on 24)

The method of claim 24, wherein the subject is a female.

### Claim 36

A method comprising:
obtaining a recombinant human GDNF from plant cells; and
formulating a topical formulation comprising a recombinant GDNF.

### Claim 37 (depends on 36)

The method of claim 36, wherein the topical formulation is an emulsion.

### Claim 38

A method for promoting hair growth comprising:
administering to the scalp of a subject a therapeutically effective amount of a topical formulation comprising recombinant human glial cell-derived neurotrophic factor (GDNF), wherein the therapeutically effective amount increases the number of hair follicles in the scalp of the subject, and wherein the subject has androgenetic alopecia.

### Claim 39 (depends on 38)

The method of claim 38, wherein the subject is female.

### Claim 40 (depends on 38)

The method of claim 38, wherein the topical formulation is an emulsion.

### Claim 41

A method for promoting hair growth comprising:
administering to the scalp of a subject a therapeutically effective amount of a topical formulation comprising recombinant human glial cell-derived neurotrophic factor (GDNF), wherein the therapeutically effective amount increases the number of hair follicles in the scalp of the subject, and wherein the subject has acute or chronic telogen effluvium.

### Claim 42 (depends on 41)

The method of claim 41, wherein the subject is female.

### Claim 43 (depends on 41)

The method of claim 41, wherein the topical formulation is an emulsion.
